Assetmark Inc. Decreases Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Assetmark Inc. trimmed its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 10.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,051 shares of the company’s stock after selling 118 shares during the period. Assetmark Inc.’s holdings in Addus HomeCare were worth $132,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the company. Victory Capital Management Inc. grew its holdings in Addus HomeCare by 14.0% during the 4th quarter. Victory Capital Management Inc. now owns 96,832 shares of the company’s stock valued at $12,138,000 after purchasing an additional 11,872 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after purchasing an additional 214 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after purchasing an additional 148 shares during the last quarter. Proficio Capital Partners LLC bought a new position in Addus HomeCare during the 4th quarter valued at about $1,933,000. Finally, Oppenheimer & Co. Inc. grew its holdings in Addus HomeCare by 21.0% during the 4th quarter. Oppenheimer & Co. Inc. now owns 6,038 shares of the company’s stock valued at $757,000 after purchasing an additional 1,047 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Insider Activity at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Performance

Shares of ADUS opened at $90.28 on Friday. The company has a 50 day moving average price of $115.98 and a 200-day moving average price of $123.59. Addus HomeCare Co. has a fifty-two week low of $87.88 and a fifty-two week high of $136.72. The stock has a market capitalization of $1.64 billion, a PE ratio of 20.66, a PEG ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. Equities research analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. JMP Securities began coverage on shares of Addus HomeCare in a report on Monday, December 16th. They set an “outperform” rating and a $150.00 price target on the stock. Macquarie restated an “outperform” rating and issued a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Finally, Oppenheimer upped their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $132.78.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.